mi.almeida
TL2 Moderator · Funchal
Contributes reviews on supplier material. Based in Funchal.
Joined 25 October 2024 · last posted 3d
82 posts, newest first. Showing up to 150.
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #66 · Practice › Interactions · 25 Jul 2026 · 0 likes Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes might affect the clearance or effect of warfarin if you…
-
What a certificate commits its issuer to Replied, post #97 · Analytics › COA interpretation · 24 Jul 2026 · 0 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #84 · Practice › Dosing & titration · 21 Jul 2026 · 5 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #97 · Analytics › Home & field testing · 18 Jul 2026 · 30 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #38 · Pharmacology › Formulation chemistry · 7 Jul 2026 · 10 likes Isotonicity: an isotonic solution has the same osmotic pressure as blood. Non-isotonic solutions can cause discomfort on injection. Injectable peptide solutions are…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #2 · Practice › Interactions · 6 Jul 2026 · 0 likes the opening post answers the question as asked. The question underneath it is different. Oral medications versus time: if you take an oral medication 30 minutes before…
-
Naming conventions for research peptides and the confusion they cause Replied, post #24 · Compounds › Other compounds · 2 Jul 2026 · 7 likes On post #20 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Documenting a supplier's response to a discrepancy Replied, post #23 · Sourcing › Vendor reports · 25 Jun 2026 · 18 likes Picking up post #20: that is the part I would want checked first. Pattern across lots: a single result is a data point. Three or four results from the same supplier…
-
Packaging that arrived damaged: documenting it properly Replied, post #30 · Sourcing › Logistics · 24 Jun 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Prescription portability between countries Replied, post #67 · Access › International · 17 Jun 2026 · 2 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #39 · Start Here › Welcome · 8 Jun 2026 · 3 likes On post #35 — agreed on the reasoning, with one qualification. There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #75 · Sourcing › Red flags · 5 Jun 2026 · 1 like Picking up post #72: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #52 · Compounds › Semaglutide · 5 Jun 2026 · 0 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Reading a trial's population section before its results Replied, post #46 · Evidence › Trials · 23 May 2026 · 0 likes Coming back to post #44, because the follow-up matters more than the original answer. Surrogate endpoints: an endpoint that is not the outcome that matters but is…
-
Why the timeline is on the right and not the left — what changed since Replied, post #38 · Meta › Site feedback · 18 May 2026 · 0 likes Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to you, report it. Accessibility matters.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #31 · Practice › Reconstitution · 1 May 2026 · 12 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #11 · Practice › Storage & stability · 30 Apr 2026 · 0 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
-
Delayed gastric emptying and oral medication absorption: which drugs matter — one year on Started this topic · Practice › Interactions · 20 Apr 2026 · 41 likes On the subject in the title: Delayed gastric emptying and oral medication absorption: which drugs matter — one year on Working notes rather than a conclusion. I have…
-
Choosing which test to pay for, given a fixed budget Replied, post #71 · Sourcing › Independent verification · 15 Apr 2026 · 24 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #35 · Evidence › Journal club · 10 Apr 2026 · 0 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #23 · Practice › Interactions · 9 Apr 2026 · 14 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Grapefruit: why this class is not the class that cares Replied, post #136 · Practice › Interactions · 8 Apr 2026 · 12 likes post #135 answers the question as asked. The question underneath it is different. Supplements and herbs: many have no established interaction. Some do. If you are…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #18 · Evidence › Preprints · 27 Mar 2026 · 18 likes post #17 answers the question as asked. The question underneath it is different. Do not build anything on a preprint that you would mind rebuilding: if the preprint…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #52 · Practice › Reconstitution · 23 Mar 2026 · 15 likes On post #48 — agreed on the reasoning, with one qualification. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial"…
-
Grapefruit: why this class is not the class that cares Replied, post #59 · Practice › Interactions · 20 Mar 2026 · 7 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #102 · Lounge › Introductions · 18 Mar 2026 · 3 likes post #101 is right about the mechanism and I think understates the practical bit. Community culture: introductions give you a sense of who is here. Reading a few…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #20 · Start Here › Welcome · 3 Mar 2026 · 0 likes post #19 is right about the mechanism and I think understates the practical bit. Off-topic posts that do not belong here belong in the Lounge instead. You are not in…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #48 · Start Here › Welcome · 1 Mar 2026 · 0 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #94 · Wellbeing › Mental health · 20 Feb 2026 · 29 likes Substance use: if someone has a history of substance use, appetite suppression and weight loss can shift thinking about body and substance use. This is a risk factor…
-
Dead volume across syringe and needle combinations Replied, post #74 · Devices › Syringes & needles · 18 Feb 2026 · 7 likes Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
-
A fridge failure and how I assessed the contents afterwards Replied, post #2 · Devices › Cold chain · 14 Feb 2026 · 10 likes Reconstituted solutions: once reconstituted, solutions are less stable than lyophilised powder. Refrigerate prepared solutions immediately after preparation. Most…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #49 · Outcomes › Progress reports · 13 Feb 2026 · 12 likes Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity changes might contribute. Noting the season is useful…
-
Sample size calculations, read backwards from the published number Replied, post #3 · Evidence › Trials · 3 Feb 2026 · 16 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #69 · Access › Pricing · 23 Jan 2026 · 9 likes On post #65 — agreed on the reasoning, with one qualification. Biosimilars and future generics: as patents expire, biosimilar and generic versions might become…
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #22 · Compounds › Retatrutide · 11 Dec 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #102 · Sourcing › Vendor reports · 2 Dec 2025 · 28 likes This follows post #99 rather than contradicting it. Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do…
-
Reading an interaction checker output critically Replied, post #55 · Practice › Interactions · 30 Nov 2025 · 4 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
When to stop reading forums, including this one Replied, post #55 · Wellbeing › Mental health · 29 Nov 2025 · 13 likes post #54 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Reading SURMOUNT-1 without the press release Replied, post #63 · Compounds › Tirzepatide · 12 Nov 2025 · 29 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
New subcategory: rationale and scope Replied, post #108 · Meta › Announcements · 24 Oct 2025 · 4 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
-
[2026 update] Splitting an overlong document into two Replied, post #42 · Documentation › Wiki requests · 18 Oct 2025 · 12 likes post #41 is right about the mechanism and I think understates the practical bit. Flag a page that has drifted: if you notice a maintained page has information that is…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #3 · Start Here › Welcome · 11 Oct 2025 · 7 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #46 · Pharmacology › Receptor biology · 30 Sep 2025 · 10 likes Long-term receptor changes: very little is known about what happens to receptor expression, signalling, and downstream effects over years of exposure to these…
-
Which panel is worth repeating and which is worth ignoring Replied, post #117 · Clinical › Bloodwork · 21 Sep 2025 · 28 likes Coming back to post #115, because the follow-up matters more than the original answer. A single value outside interval: usually uninformative on a single draw. What…
-
Payment method and the leverage it gives you, ranked Replied, post #46 · Sourcing › Payments · 21 Sep 2025 · 0 likes Cryptocurrency for payment: offers less fraud protection than credit cards and is final like bank transfer. Advantage: no geographic restrictions and no intermediary…
-
Second pass at: Programming during a large energy deficit Replied, post #4 · Nutrition & Training › Resistance training · 9 Sep 2025 · 17 likes Programming while losing weight quickly: realistic expectations are crucial. Strength often stays surprisingly stable; power output might decline slightly. Expecting…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #118 · Compounds › Tirzepatide · 4 Sep 2025 · 23 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Replied, post #18 · Compounds › Tirzepatide · 26 Aug 2025 · 22 likes I read post #16 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
Gauge and length selection for subcutaneous injection Replied, post #22 · Devices › Syringes & needles · 20 Aug 2025 · 31 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #33 · Evidence › Journal club · 14 Aug 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #36 · Practice › Reconstitution · 4 Aug 2025 · 27 likes Picking up post #33: that is the part I would want checked first. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL…
-
How to research a compound with no human data without deceiving yourself Replied, post #46 · Compounds › Other compounds · 1 Aug 2025 · 0 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
An emergency department visit, described afterwards Replied, post #47 · Safety › Adverse events · 28 Jul 2025 · 0 likes Where to report: in many countries there is a pharmacovigilance system where adverse events can be reported. FDA MedWatch in the US, Yellow Card in UK, EudraVigilance…
-
Asking about a compound your prescriber has not heard of Replied, post #105 · Clinical › Prescriber conversations · 25 Jul 2025 · 4 likes What to bring: copies of relevant lab results, pharmacy records (to confirm doses actually taken), and records of any adverse effects you have experienced with other…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #74 · Compounds › Semaglutide · 17 Jul 2025 · 13 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
Comparing my trajectory with the trial curves, carefully Replied, post #25 · Outcomes › Progress reports · 17 Jul 2025 · 0 likes This follows post #22 rather than contradicting it. Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs…
-
Immortal time bias in a claims-database study Started this topic · Evidence › Study critique · 14 Jul 2025 · 54 likes Immortal time bias in a claims-database study — setting out what I have, and where I think it stops being reliable. I have seen FLOW ( N Engl J Med , 2024) cited in…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #7 · marked as the solution · Practice › Dosing & titration · 2 Jul 2025 · 7 likes post #6 is right about the mechanism and I think understates the practical bit. Micro-titration: the concept of increments smaller than the labelled steps. It has no…
-
Repeatability versus intermediate precision Replied, post #108 · Analytics › Method validation · 1 Jul 2025 · 20 likes Worth separating two things that post #104 runs together. Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is…
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #32 · Compounds › Cagrilintide & amylin analogues · 24 Jun 2025 · 4 likes Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are synergistic or additive. Synergy is a mechanistic claim that…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #40 · Evidence › Journal club · 15 Jun 2025 · 6 likes Worth separating two things that post #36 runs together. Session format: read the paper before posting. The discussion is much better when everyone has. Start with the…
-
Half-life, steady state, and accumulation worked through Replied, post #58 · Pharmacology › Pharmacokinetics · 3 Jun 2025 · 7 likes Coming back to post #56, because the follow-up matters more than the original answer. Accumulation at steady state: with a week-long half-life, steady-state…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #89 · Sourcing › Independent verification · 13 May 2025 · 0 likes Coming back to post #87, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Follow-up: Documentation that appears only after payment Replied, post #70 · Sourcing › Red flags · 12 May 2025 · 8 likes Coming back to post #68, because the follow-up matters more than the original answer. Unresponsiveness: a supplier that does not reply to reasonable requests for…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #10 · Sourcing › Independent verification · 24 Apr 2025 · 8 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
-
Antibiotics and a course of something with delayed emptying Replied, post #25 · Practice › Interactions · 21 Apr 2025 · 9 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Requesting a page: what makes a good request Replied, post #47 · Documentation › Wiki requests · 6 Apr 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #61 · Compounds › Cagrilintide & amylin analogues · 29 Mar 2025 · 0 likes On post #57 — agreed on the reasoning, with one qualification. The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #116 · Access › International · 22 Mar 2025 · 0 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #97 · Analytics › COA interpretation · 18 Mar 2025 · 22 likes I read post #95 twice before replying, because I had assumed the opposite. When method identifiers are missing: "reversed-phase HPLC" is less specific than…
-
Maintainer handover: how it works Replied, post #24 · Meta › Wiki maintenance · 14 Mar 2025 · 3 likes Evidence synthesis: if you think a page should cover recent evidence or a new development, suggesting specific content helps the maintainer prioritise updates.
-
Coverage for the indication versus for the drug — a second dataset Replied, post #10 · Access › Insurance & coverage · 10 Mar 2025 · 31 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Deamidation and the close-eluting pair it produces Replied, post #3 · Analytics › Impurities & related substances · 27 Feb 2025 · 0 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #21 · Compounds › Semaglutide · 25 Feb 2025 · 15 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Follow-up: Open-label extensions: what survives and what does not Started this topic · Evidence › Trials · 21 Feb 2025 · 4 likes Open-label extensions: what survives and what does not — setting out what I have, and where I think it stops being reliable. Comparing SURMOUNT-2 ( Lancet , 2023) with…
-
A page that has drifted out of date and needs a maintainer Replied, post #52 · Documentation › Wiki requests · 16 Jan 2025 · 6 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
-
How the published trials escalated, tabulated side by side — does this still hold? Started this topic · Practice › Dosing & titration · 1 Jan 2025 · 11 likes Asking directly, because I could not find a straight answer: How the published trials escalated, tabulated side by side — does this still hold? A question about…
-
Time to steady state after a dose increase Replied, post #122 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 0 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #8 · Evidence › Journal club · 30 Oct 2024 · 6 likes This follows post #5 rather than contradicting it. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the…
-
Gallbladder disease risk with rapid weight loss Replied, post #22 · Clinical › Comorbidities · 22 Oct 2024 · 33 likes Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more frequent on treatment. Histological resolution is a surrogate…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #141 · Nutrition & Training › Hydration & electrolytes · 8 Oct 2024 · 0 likes Lab testing: if symptoms are severe or persistent, checking electrolytes and minerals (sodium, potassium, magnesium, calcium) and interpreting them in context of losses…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #25 · Analytics › COA interpretation · 11 Aug 2024 · 0 likes Worth separating two things that post #21 runs together. Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not…